Can a Low-Cost portable simulator retrain driving skills in neurological conditions?

NCT ID NCT03969927

Completed Symptom relief Sponsor: University of Kansas Medical Center Source: ClinicalTrials.gov ↗

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This pilot study is testing whether a low-cost, portable driving simulator can help retrain driving skills in people who have had a stroke or who live with Parkinson's disease or multiple sclerosis. Participants will be randomly assigned to train on either the portable simulator or a larger, high-fidelity simulator. The study will compare how user-friendly each device is, how often simulator sickness occurs, and whether driving performance improves similarly with both.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Portable driving simulator (low-fidelity) versus high-fidelity fixed-base simulator
What this could lead to: If the portable simulator works as well as the high-fidelity one, it could make driving retraining more accessible and affordable for people with neurological conditions.
What could go wrong: This is a small pilot study, so results may not apply broadly. The portable simulator may not be as effective as the high-fidelity version, and simulator sickness could still occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis Parkinson disease stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS PARKINSON DISEASE STROKE

Contacts and locations

Locations

Abiodun Akinwuntan

Kansas City, Kansas, 66160-8500, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.